{"cluster": 58, "subcluster": 8, "abstract_phrases": [{"text": "controlled studies", "rank": 0.067}, {"text": "studies", "rank": 0.066}, {"text": "published studies", "rank": 0.066}, {"text": "methods related studies", "rank": 0.064}, {"text": "nonrandomized studies", "rank": 0.064}], "title_phrases": [{"text": "systematic review", "rank": 0.148}, {"text": "coronavirus covid-19 disease", "rank": 0.128}, {"text": "systematic reviewefficacy", "rank": 0.115}, {"text": "analogue-naive chronic hepatitis b", "rank": 0.108}, {"text": "randomised controlled trialspotential", "rank": 0.102}], "title_abstract_phrases": [{"text": "coronavirus covid-19 disease", "rank": 0.071}, {"text": "controlled studies", "rank": 0.067}, {"text": "studies", "rank": 0.064}, {"text": "severe adverse event rates", "rank": 0.064}, {"text": "published studies", "rank": 0.064}]}